![whodrug atc4 code whodrug atc4 code](https://i.ytimg.com/vi/OkprieQfo9g/maxresdefault.jpg)
WHODrug Global is also an indispensable source when interpreting and evaluating drug safety issues in VigiBase, WHO’s global database of adverse event reports. This is because using WHODrug to code data supports more effective analysis, speeding up the regulatory submission process. WHODrug Global’s standardised data makes it easier to identify drug-related problems in clinical trials and pharmacovigilance, helping you to develop safer medicines.
#WHODRUG ATC4 CODE HOW TO#
Learn more about how to implement WHODrug Global here. The data is continuously updated, with new releases twice a year, on 1 March and 1 September, and available to subscribers either as text and csv files or via our browsing tool, WHODrug Insight. Products and substances registered by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are also routinely recorded. The conventional medicines include prescription-only products, over-the-counter (OTC) and pharmacist-dispensed preparations, as well as biotech and blood products, diagnostic substances and contrast media.
![whodrug atc4 code whodrug atc4 code](https://i3.ytimg.com/vi/gUhlAh8R9k0/hqdefault.jpg)
WHODrug data covers both conventional medicines and herbal remedies.
![whodrug atc4 code whodrug atc4 code](https://docplayer.net/docs-images/65/52245242/images/11-2.jpg)
The dictionary is used to identify drug names and evaluate medicinal product information, including active ingredients and products’ anatomical and therapeutic classifications, from nearly 150 countries. With its unique drug code hierarchy and extensive coverage, it provides a consistent drug dictionary with exact terminology when coding concomitant medications. WHODrug Global is the international reference for medicinal product information and it is maintained by the Uppsala Monitoring Centre.